DataSet	Human Name	NEST ID	GenesFixed	n_Genes	log2_n_Genes	GO term	GO ID	GSEA genes	n_overlap_GSEA	perc_overlap_GSEA	P-value	Adjusted P-value	LLM Name	LLM Analysis	n_overlap_LLM	perc_overlap_LLM	References	LLM_name_human_name_sim	GO_term_human_name_sim	winner	humanConsensus	OverridingDecision
NeST	Extended mismatch repair complex	NEST:125	ERCC1 ERCC4 MLH1 MLH3 MSH2 MSH3 MSH6 PMS1 PMS2 SLX4	10	3.321928094887362	Mismatch Repair 	GO:0006298	MSH6;MSH2;MSH3;PMS2;MLH1;MLH3;PMS1	7	70	2.2663315591582227e-19	1.5660316092380094e-17	DNA Mismatch Repair and Excision Repair	"The primary biological process performed by this system of interacting proteins is DNA mismatch repair and excision repair. These processes are crucial for maintaining genomic stability and preventing mutations.

1. ERCC1 and ERCC4: These proteins form a heterodimeric endonuclease complex involved in nucleotide excision repair (NER). ERCC1 is responsible for DNA damage recognition, while ERCC4 provides the catalytic activity for DNA incision. Together, they remove DNA lesions caused by UV radiation and other genotoxic agents, preventing mutations and maintaining genomic stability.

2. MLH1, MLH3, PMS1, and PMS2: These proteins are part of the MutL family and play essential roles in DNA mismatch repair (MMR). MLH1 forms heterodimers with PMS2 (MutLα), MLH3 (MutLγ), and PMS1 (MutLβ). MutLα is the primary complex involved in MMR, while MutLγ and MutLβ have specialized roles in meiotic recombination and mutation avoidance, respectively. These complexes coordinate with MutS family proteins (MSH2, MSH3, and MSH6) to recognize and repair DNA mismatches, insertions, and deletions, ensuring accurate DNA replication and preventing mutations.

3. MSH2, MSH3, MSH6: These proteins belong to the MutS family and are involved in DNA mismatch repair (MMR). MSH2 forms heterodimers with MSH6 (MutSα) and MSH3 (MutSβ). MutSα recognizes base mismatches and small insertion/deletion loops, while MutSβ recognizes larger insertion/deletion loops. These complexes initiate the MMR process by binding to DNA mismatches and recruiting MutL family proteins to repair the errors.

4. SLX4: This protein acts as a scaffold for multiple structure-specific endonucleases, including ERCC1-ERCC4, and is involved in the repair of DNA interstrand crosslinks, double-strand breaks, and replication fork collapse. SLX4 interacts with ERCC1 and ERCC4, coordinating their activities in nucleotide excision repair and ensuring the efficient removal of DNA lesions.

In conclusion, the primary biological process performed by this system of interacting proteins is DNA mismatch repair and excision repair, which are essential for maintaining genomic stability and preventing mutations. The proteins work together in a coordinated manner to recognize and repair DNA errors, ensuring accurate DNA replication and preventing the accumulation of mutations that could lead to diseases such as cancer."	10	100	"The primary biological process performed by this system of interacting proteins is DNA mismatch repair and excision repair. These processes are crucial for maintaining genomic stability and preventing mutations.

1. ERCC1 and ERCC4: These proteins form a heterodimeric endonuclease complex involved in nucleotide excision repair (NER). ERCC1 is responsible for DNA damage recognition, while ERCC4 provides the catalytic activity for DNA incision. Together, they remove DNA lesions caused by UV radiation and other genotoxic agents, preventing mutations and maintaining genomic stability.[1][2][3]

2. MLH1, MLH3, PMS1, and PMS2: These proteins are part of the MutL family and play essential roles in DNA mismatch repair (MMR). MLH1 forms heterodimers with PMS2 (MutLα), MLH3 (MutLγ), and PMS1 (MutLβ). MutLα is the primary complex involved in MMR, while MutLγ and MutLβ have specialized roles in meiotic recombination and mutation avoidance, respectively. These complexes coordinate with MutS family proteins (MSH2, MSH3, and MSH6) to recognize and repair DNA mismatches, insertions, and deletions, ensuring accurate DNA replication and preventing mutations.[4][5][6]

3. MSH2, MSH3, MSH6: These proteins belong to the MutS family and are involved in DNA mismatch repair (MMR). MSH2 forms heterodimers with MSH6 (MutSα) and MSH3 (MutSβ). MutSα recognizes base mismatches and small insertion/deletion loops, while MutSβ recognizes larger insertion/deletion loops. These complexes initiate the MMR process by binding to DNA mismatches and recruiting MutL family proteins to repair the errors.[7][8][9]

4. SLX4: This protein acts as a scaffold for multiple structure-specific endonucleases, including ERCC1-ERCC4, and is involved in the repair of DNA interstrand crosslinks, double-strand breaks, and replication fork collapse. SLX4 interacts with ERCC1 and ERCC4, coordinating their activities in nucleotide excision repair and ensuring the efficient removal of DNA lesions.[10][11][12]

In conclusion, the primary biological process performed by this system of interacting proteins is DNA mismatch repair and excision repair, which are essential for maintaining genomic stability and preventing mutations. The proteins work together in a coordinated manner to recognize and repair DNA errors, ensuring accurate DNA replication and preventing the accumulation of mutations that could lead to diseases such as cancer.

========================================================================================================================================================================================================
[1] Biggerstaff, M, Szymkowski, D E, Wood, R D. ""Co-correction of the ERCC1, ERCC4 and xeroderma pigmentosum group F DNA repair defects in vitro."" The EMBO journal, 1993, pp. 3685-92.
[2] Jiang, Chunming, Shen, Fang, Du, Jianmin, Wang, Xiaohua, Su, Jin, Liu, Zhanli, Huang, Xianmei. ""DNA repair gene ERCC1 polymorphisms and glioma susceptibility among Chinese population: a meta-analysis."" International journal of clinical and experimental medicine, 2015, pp. 10248-55.
[3] van Vuuren, A J, Appeldoorn, E, Odijk, H, Humbert, S, Moncollin, V, Eker, A P, Jaspers, N G, Egly, J M, Hoeijmakers, J H. ""Partial characterization of the DNA repair protein complex, containing the ERCC1, ERCC4, ERCC11 and XPF correcting activities."" Mutation research, 1995, pp. 25-39.
[4] Rogacheva, Maria V, Manhart, Carol M, Chen, Cheng, Guarne, Alba, Surtees, Jennifer, Alani, Eric. ""Mlh1-Mlh3, a meiotic crossover and DNA mismatch repair factor, is a Msh2-Msh3-stimulated endonuclease."" The Journal of biological chemistry, 2014, pp. 5664-73.
[5] Prolla, T A, Pang, Q, Alani, E, Kolodner, R D, Liskay, R M. ""MLH1, PMS1, and MSH2 interactions during the initiation of DNA mismatch repair in yeast."" Science (New York, N.Y.), 1994, pp. 1091-3.
[6] Al-Sweel, Najla, Raghavan, Vandana, Dutta, Abhishek, Ajith, V P, Di Vietro, Luigi, Khondakar, Nabila, Manhart, Carol M, Surtees, Jennifer A, Nishant, K T, Alani, Eric. ""mlh3 mutations in baker's yeast alter meiotic recombination outcomes by increasing noncrossover events genome-wide."" PLoS genetics, 2017, pp. e1006974.
[7] Edelbrock, Michael A, Kaliyaperumal, Saravanan, Williams, Kandace J. ""Structural, molecular and cellular functions of MSH2 and MSH6 during DNA mismatch repair, damage signaling and other noncanonical activities."" Mutation research, 2013, pp. 53-66.
[8] Stark, Andreas M, Doukas, Alexander, Hugo, Heinz-Herrmann, Hedderich, Jürgen, Hattermann, Kirsten, Maximilian Mehdorn, H, Held-Feindt, Janka. ""Expression of DNA mismatch repair proteins MLH1, MSH2, and MSH6 in recurrent glioblastoma."" Neurological research, 2015, pp. 95-105.
[9] Rogacheva, Maria V, Manhart, Carol M, Chen, Cheng, Guarne, Alba, Surtees, Jennifer, Alani, Eric. ""Mlh1-Mlh3, a meiotic crossover and DNA mismatch repair factor, is a Msh2-Msh3-stimulated endonuclease."" The Journal of biological chemistry, 2014, pp. 5664-73.
[10] Young, Sarah J, West, Stephen C. ""Coordinated roles of SLX4 and MutSβ in DNA repair and the maintenance of genome stability."" Critical reviews in biochemistry and molecular biology, 2021, pp. 157-177.
[11] Biggerstaff, M, Szymkowski, D E, Wood, R D. ""Co-correction of the ERCC1, ERCC4 and xeroderma pigmentosum group F DNA repair defects in vitro."" The EMBO journal, 1993, pp. 3685-92.
[12] van Vuuren, A J, Appeldoorn, E, Odijk, H, Humbert, S, Moncollin, V, Eker, A P, Jaspers, N G, Egly, J M, Hoeijmakers, J H. ""Partial characterization of the DNA repair protein complex, containing the ERCC1, ERCC4, ERCC11 and XPF correcting activities."" Mutation research, 1995, pp. 25-39.
"	0.789281	0.7637749	Tied	Tied	NA
NeST	RPA complex associated proteins	NEST:134	ATM ATR BLM BRCA1 XPA XPC	6	2.584962500721156	DNA Metabolic Process 	GO:0006259	BLM;XPA;ATM;XPC;BRCA1;ATR	6	100	8.464498328454512e-12	8.651916355170181e-10	DNA Damage Response and Repair	"The most prominent biological process performed by this system of interacting proteins is DNA damage response and repair. These proteins play crucial roles in maintaining genomic stability and preventing the accumulation of mutations that can lead to diseases such as cancer.

1. ATM and ATR: These proteins are key kinases involved in the DNA damage response. They are activated by different types of DNA damage, such as double-strand breaks (ATM) and replication stress (ATR). Upon activation, they phosphorylate numerous downstream targets, including other proteins in this system, to initiate the appropriate repair pathways.

2. BLM: This protein is a RecQ helicase that plays a role in DNA repair, replication, and recombination. BLM is involved in resolving complex DNA structures, such as Holliday junctions, and preventing genome instability. Mutations in BLM can lead to Bloom syndrome, a rare disorder characterized by increased cancer susceptibility.

3. BRCA1: This protein is a tumor suppressor involved in multiple DNA repair pathways, including homologous recombination and non-homologous end joining. BRCA1 interacts with several other proteins in this system, such as ATM and ATR, to coordinate the DNA damage response. Mutations in BRCA1 are associated with an increased risk of breast and ovarian cancer.

4. XPA and XPC: These proteins are involved in nucleotide excision repair (NER), a pathway that removes bulky DNA lesions, such as those caused by UV radiation. XPC is responsible for damage recognition, while XPA plays a role in damage verification and recruitment of other NER factors. Defects in XPA or XPC can lead to xeroderma pigmentosum, a rare disorder characterized by extreme sensitivity to sunlight and increased skin cancer risk.

In conclusion, the interacting proteins ATM, ATR, BLM, BRCA1, XPA, and XPC are essential for maintaining genomic stability by coordinating the DNA damage response and participating in various DNA repair pathways. Their dysfunction can lead to genome instability and increased susceptibility to cancer."	6	100	"The most prominent biological process performed by this system of interacting proteins is DNA damage response and repair. These proteins play crucial roles in maintaining genomic stability and preventing the accumulation of mutations that can lead to diseases such as cancer.

1. ATM and ATR: These proteins are key kinases involved in the DNA damage response. They are activated by different types of DNA damage, such as double-strand breaks (ATM) and replication stress (ATR). Upon activation, they phosphorylate numerous downstream targets, including other proteins in this system, to initiate the appropriate repair pathways.[1][2][3]

2. BLM: This protein is a RecQ helicase that plays a role in DNA repair, replication, and recombination. BLM is involved in resolving complex DNA structures, such as Holliday junctions, and preventing genome instability. Mutations in BLM can lead to Bloom syndrome, a rare disorder characterized by increased cancer susceptibility.[4][5][6]

3. BRCA1: This protein is a tumor suppressor involved in multiple DNA repair pathways, including homologous recombination and non-homologous end joining. BRCA1 interacts with several other proteins in this system, such as ATM and ATR, to coordinate the DNA damage response. Mutations in BRCA1 are associated with an increased risk of breast and ovarian cancer.[7][8][9]

4. XPA and XPC: These proteins are involved in nucleotide excision repair (NER), a pathway that removes bulky DNA lesions, such as those caused by UV radiation. XPC is responsible for damage recognition, while XPA plays a role in damage verification and recruitment of other NER factors. Defects in XPA or XPC can lead to xeroderma pigmentosum, a rare disorder characterized by extreme sensitivity to sunlight and increased skin cancer risk.[10][11][12]

In conclusion, the interacting proteins ATM, ATR, BLM, BRCA1, XPA, and XPC are essential for maintaining genomic stability by coordinating the DNA damage response and participating in various DNA repair pathways. Their dysfunction can lead to genome instability and increased susceptibility to cancer.[13][14][15]

========================================================================================================================================================================================================
[1] Blackford, Andrew N, Jackson, Stephen P. ""ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response."" Molecular cell, 2017, pp. 801-817.
[2] Zhang, Jingjing, Wu, Qiong, Zhu, Lucheng, Xie, Shujun, Tu, Linglan, Yang, Yuhong, Wu, Kan, Zhao, Yanyan, Wang, Yuqing, Xu, Yasi, Chen, Xueqin, Ma, Shenglin, Zhang, Shirong. ""SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer."" Cancer letters, 2022, pp. 268-283.
[3] Lopez-Pelaez, Marta, Young, Lucy, Vazquez-Chantada, Mercedes, Nelson, Nadine, Durant, Steve, Wilkinson, Robert W, Poon, Edmund, Gaspar, Miguel, Valge-Archer, Viia, Smith, Paul, Dovedi, Simon J. ""Targeting DNA damage response components induces enhanced STING-dependent type-I IFN response in ATM deficient cancer cells and drives dendritic cell activation."" Oncoimmunology, 2022, pp. 2117321.
[4] Dhar, Srijita, Brosh, Robert M. ""BLM's balancing act and the involvement of FANCJ in DNA repair."" Cell cycle (Georgetown, Tex.), 2018, pp. 2207-2220.
[5] Bendtsen, Kristian Moss, Jensen, Martin Borch, May, Alfred, Rasmussen, Lene Juel, Trusina, Ala, Bohr, Vilhelm A, Jensen, Mogens H. ""Dynamics of the DNA repair proteins WRN and BLM in the nucleoplasm and nucleoli."" European biophysics journal : EBJ, 2014, pp. 509-16.
[6] Frank, Bernd, Hoffmeister, Michael, Klopp, Norman, Illig, Thomas, Chang-Claude, Jenny, Brenner, Hermann. ""Colorectal cancer and polymorphisms in DNA repair genes WRN, RMI1 and BLM."" Carcinogenesis, 2010, pp. 442-5.
[7] Yoshida, Kiyotsugu, Miki, Yoshio. ""Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage."" Cancer science, 2004, pp. 866-71.
[8] Jin, Mei Hua, Oh, Do-Youn. ""ATM in DNA repair in cancer."" Pharmacology & therapeutics, 2019, pp. 107391.
[9] Tarsounas, Madalena, Sung, Patrick. ""The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication."" Nature reviews. Molecular cell biology, 2020, pp. 284-299.
[10] Zebian, Abir, Shaito, Abdullah, Mazurier, Frédéric, Rezvani, Hamid Reza, Zibara, Kazem. ""XPC beyond nucleotide excision repair and skin cancers."" Mutation research. Reviews in mutation research, 2019, pp. 108286.
[11] Lindsey-Boltz, Laura A, Yang, Yanyan, Kose, Cansu, Deger, Nazli, Eynullazada, Khagani, Kawara, Hiroaki, Sancar, Aziz. ""Nucleotide excision repair in Human cell lines lacking both XPC and CSB proteins."" Nucleic acids research, 2023, pp. 6238-6245.
[12] Musich, Phillip R, Li, Zhengke, Zou, Yue. ""Xeroderma Pigmentosa Group A (XPA), Nucleotide Excision Repair and Regulation by ATR in Response to Ultraviolet Irradiation."" Advances in experimental medicine and biology, 2017, pp. 41-54.
[13] Blackford, Andrew N, Jackson, Stephen P. ""ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response."" Molecular cell, 2017, pp. 801-817.
[14] Wu, Chenming, Chang, Yiming, Chen, Junliang, Su, Yang, Li, Lei, Chen, Yuping, Li, Yunhui, Wu, Jinhuan, Huang, Jinzhou, Zhao, Fei, Wang, Wenrui, Yin, Hui, Wang, Shunli, Jin, Mingpeng, Lou, Zhenkun, Zhu, Wei-Guo, Luo, Kuntian, Zhang, Jie, Yuan, Jian. ""USP37 regulates DNA damage response through stabilizing and deubiquitinating BLM."" Nucleic acids research, 2021, pp. 11224-11240.
[15] Foo, Tzeh Keong, Xia, Bing. ""BRCA1-Dependent and Independent Recruitment of PALB2-BRCA2-RAD51 in the DNA Damage Response and Cancer."" Cancer research, 2022, pp. 3191-3197.
"	0.41036648	0.22505553	LLM	LLM	NA
NeST	MAPK signaling	NEST:256	ERBB2 ERBB4 FGFR2 FGFR4 HRAS KRAS	6	2.584962500721156	Positive Regulation Of Phosphorylation 	GO:0042327	ERBB4;ERBB2;KRAS;FGFR4;HRAS;FGFR2	6	100	2.224544671767216e-12	5.07196185162925e-10	Receptor Tyrosine Kinase Signaling	"The most prominent biological process performed by the interacting proteins ERBB2, ERBB4, FGFR2, FGFR4, HRAS, and KRAS is receptor tyrosine kinase (RTK) signaling. This process is critical for cellular growth, differentiation, and survival.

1. ERBB2 and ERBB4: Both proteins belong to the epidermal growth factor receptor (EGFR) family, which are receptor tyrosine kinases. They play a crucial role in cell proliferation and differentiation by binding to specific ligands, leading to the activation of downstream signaling pathways, such as the MAPK and PI3K/AKT pathways. ERBB2 is known to form heterodimers with other EGFR family members, enhancing the signaling capacity of the receptor complex.

2. FGFR2 and FGFR4: These proteins are members of the fibroblast growth factor receptor (FGFR) family, which are also receptor tyrosine kinases. They are involved in various cellular processes, including cell growth, differentiation, and migration. FGFR2 and FGFR4 bind to fibroblast growth factors (FGFs), leading to receptor dimerization and activation of downstream signaling pathways, such as the RAS/MAPK and PI3K/AKT pathways.

3. HRAS and KRAS: Both proteins are members of the RAS family of small GTPases, which function as molecular switches in various signaling pathways, including the RTK signaling pathway. They are involved in transmitting signals from activated RTKs to downstream effectors, such as the RAF/MEK/ERK and PI3K/AKT pathways. HRAS and KRAS are known to play a critical role in cell proliferation, differentiation, and survival.

In conclusion, the interacting proteins ERBB2, ERBB4, FGFR2, FGFR4, HRAS, and KRAS are involved in the receptor tyrosine kinase signaling pathway, which is essential for cellular growth, differentiation, and survival. This process is initiated by the binding of specific ligands to the receptor tyrosine kinases (ERBB2, ERBB4, FGFR2, and FGFR4), leading to the activation of downstream signaling pathways, such as the RAS/MAPK and PI3K/AKT pathways, mediated by the small GTPases HRAS and KRAS."	6	100	"The most prominent biological process performed by the interacting proteins ERBB2, ERBB4, FGFR2, FGFR4, HRAS, and KRAS is receptor tyrosine kinase (RTK) signaling. This process is critical for cellular growth, differentiation, and survival.[1][2][3]

1. ERBB2 and ERBB4: Both proteins belong to the epidermal growth factor receptor (EGFR) family, which are receptor tyrosine kinases. They play a crucial role in cell proliferation and differentiation by binding to specific ligands, leading to the activation of downstream signaling pathways, such as the MAPK and PI3K/AKT pathways. ERBB2 is known to form heterodimers with other EGFR family members, enhancing the signaling capacity of the receptor complex.[4][5][6]

2. FGFR2 and FGFR4: These proteins are members of the fibroblast growth factor receptor (FGFR) family, which are also receptor tyrosine kinases. They are involved in various cellular processes, including cell growth, differentiation, and migration. FGFR2 and FGFR4 bind to fibroblast growth factors (FGFs), leading to receptor dimerization and activation of downstream signaling pathways, such as the RAS/MAPK and PI3K/AKT pathways.[7][8][9]

3. HRAS and KRAS: Both proteins are members of the RAS family of small GTPases, which function as molecular switches in various signaling pathways, including the RTK signaling pathway. They are involved in transmitting signals from activated RTKs to downstream effectors, such as the RAF/MEK/ERK and PI3K/AKT pathways. HRAS and KRAS are known to play a critical role in cell proliferation, differentiation, and survival.[10][11][12]

In conclusion, the interacting proteins ERBB2, ERBB4, FGFR2, FGFR4, HRAS, and KRAS are involved in the receptor tyrosine kinase signaling pathway, which is essential for cellular growth, differentiation, and survival. This process is initiated by the binding of specific ligands to the receptor tyrosine kinases (ERBB2, ERBB4, FGFR2, and FGFR4), leading to the activation of downstream signaling pathways, such as the RAS/MAPK and PI3K/AKT pathways, mediated by the small GTPases HRAS and KRAS.[13][14][15]

========================================================================================================================================================================================================
[1] Hoesl, Christine, Röhrl, Jennifer M, Schneider, Marlon R, Dahlhoff, Maik. ""The receptor tyrosine kinase ERBB4 is expressed in skin keratinocytes and influences epidermal proliferation."" Biochimica et biophysica acta. General subjects, 2018, pp. 958-966.
[2] Canfield, Kaleigh, Li, Jiaqi, Wilkins, Owen M, Morrison, Meghan M, Ung, Matthew, Wells, Wendy, Williams, Charlotte R, Liby, Karen T, Vullhorst, Detlef, Buonanno, Andres, Hu, Huizhong, Schiff, Rachel, Cook, Rebecca S, Kurokawa, Manabu. ""Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells."" Cell cycle (Georgetown, Tex.), 2015, pp. 648-55.
[3] Li, W, Shi, Q, Wang, W, Liu, J, Ren, J, Li, Q, Hou, F. ""KRAS status and resistance to epidermal growth factor receptor tyrosine-kinase inhibitor treatment in patients with metastatic colorectal cancer: a meta-analysis."" Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2014, pp. O370-8.
[4] Wei, Dang, Rui, Bian, Qingquan, Fan, Chen, Cai, Ping, Hu Yun, Xiaoling, Song, Hao, Weng, Jun, Gu. ""KIF11 promotes cell proliferation via ERBB2/PI3K/AKT signaling pathway in gallbladder cancer."" International journal of biological sciences, 2021, pp. 514-526.
[5] Ma, Xuejiao, Chen, Jingruo, Huang, Bohan, Fu, Shiqi, Qu, Shuai, Yu, Rong, Zhao, Yuhua. ""ErbB2-upregulated HK1 and HK2 promote breast cancer cell proliferation, migration and invasion."" Medical oncology (Northwood, London, England), 2023, pp. 154.
[6] Kedashiro, Shin, Kameyama, Takeshi, Mizutani, Kiyohito, Takai, Yoshimi. ""Stimulatory role of nectin-4 and p95-ErbB2 in multilayered T47D cell proliferation."" Genes to cells : devoted to molecular & cellular mechanisms, 2022, pp. 451-464.
[7] Fang, Xianlong, Yang, Dongmei, Luo, Hongping, Wu, Shuai, Dong, Wenjie, Xiao, Jing, Yuan, Sujing, Ni, Aimin, Zhang, Kang-Jian, Liu, Xin-Yuan, Chu, Liang. ""SNORD126 promotes HCC and CRC cell growth by activating the PI3K-AKT pathway through FGFR2."" Journal of molecular cell biology, 2017, pp. 243-255.
[8] Shi, Yuanyuan, Liu, Xuejiao, Fredimoses, Mangaladoss, Song, Mengqiu, Chen, Hanyong, Liu, Kangdong, Lee, Mee-Hyun, Dong, Zigang. ""FGFR2 regulation by picrasidine Q inhibits the cell growth and induces apoptosis in esophageal squamous cell carcinoma."" Journal of cellular biochemistry, 2018, pp. 2231-2239.
[9] Park, Jihyun, Kim, Sun Young, Kim, Ha-Jung, Kim, Kyoung-Mee, Choi, Eun Young, Kang, Myung-Soo. ""A reciprocal regulatory circuit between CD44 and FGFR2 via c-myc controls gastric cancer cell growth."" Oncotarget, 2016, pp. 28670-83.
[10] Ternet, Camille, Kiel, Christina. ""Signaling pathways in intestinal homeostasis and colorectal cancer: KRAS at centre stage."" Cell communication and signaling : CCS, 2021, pp. 31.
[11] Fitzgerald, Timothy L, Lertpiriyapong, Kvin, Cocco, Lucio, Martelli, Alberto M, Libra, Massimo, Candido, Saverio, Montalto, Giuseppe, Cervello, Melchiorre, Steelman, Linda, Abrams, Stephen L, McCubrey, James A. ""Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells."" Advances in biological regulation, 2015, pp. 65-81.
[12] Liu, Zhonglu, Liu, Feifei, Wang, Fang, Yang, Xin, Guo, Wentao. ""CircZNF609 promotes cell proliferation, migration, invasion, and glycolysis in nasopharyngeal carcinoma through regulating HRAS via miR-338-3p."" Molecular and cellular biochemistry, 2021, pp. 175-186.
[13] Hoesl, Christine, Röhrl, Jennifer M, Schneider, Marlon R, Dahlhoff, Maik. ""The receptor tyrosine kinase ERBB4 is expressed in skin keratinocytes and influences epidermal proliferation."" Biochimica et biophysica acta. General subjects, 2018, pp. 958-966.
[14] Canfield, Kaleigh, Li, Jiaqi, Wilkins, Owen M, Morrison, Meghan M, Ung, Matthew, Wells, Wendy, Williams, Charlotte R, Liby, Karen T, Vullhorst, Detlef, Buonanno, Andres, Hu, Huizhong, Schiff, Rachel, Cook, Rebecca S, Kurokawa, Manabu. ""Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells."" Cell cycle (Georgetown, Tex.), 2015, pp. 648-55.
[15] Li, W, Shi, Q, Wang, W, Liu, J, Ren, J, Li, Q, Hou, F. ""KRAS status and resistance to epidermal growth factor receptor tyrosine-kinase inhibitor treatment in patients with metastatic colorectal cancer: a meta-analysis."" Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2014, pp. O370-8.
"	0.6257839	0.399123	LLM	LLM	NA
MSigDB	ADIPOGENESIS	NA	ABCA1 ABCB8 ACAA2 ACADL ACADM ACADS ACLY ACO2 ACOX1 ADCY6 ADIG ADIPOQ ADIPOR2 AGPAT3 AIFM1 AK2 ALDH2 ALDOA ANGPT1 ANGPTL4 APLP2 APOE ARAF ARL4A ATL2 ATP1B3 ATP5PO BAZ2A BCKDHA BCL2L13 BCL6 C3 CAT CAVIN1 CAVIN2 CCNG2 CD151 CD302 CD36 CDKN2C CHCHD10 CHUK CIDEA CMBL CMPK1 COL15A1 COL4A1 COQ3 COQ5 COQ9 COX6A1 COX7B COX8A CPT2 CRAT CS CYC1 CYP4B1 DBT DDT DECR1 DGAT1 DHCR7 DHRS7 DHRS7B DLAT DLD DNAJB9 DNAJC15 DRAM2 ECH1 ECHS1 ELMOD3 ELOVL6 ENPP2 EPHX2 ESRRA ESYT1 ETFB FABP4 FAH FZD4 G3BP2 GADD45A GBE1 GHITM GPAM GPAT4 GPD2 GPHN GPX3 GPX4 GRPEL1 HADH HIBCH HSPB8 IDH1 IDH3A IDH3G IFNGR1 IMMT ITGA7 ITIH5 ITSN1 JAGN1 LAMA4 LEP LIFR LIPE LPCAT3 LPL LTC4S MAP4K3 MCCC1 MDH2 ME1 MGLL MGST3 MIGA2 MRAP MRPL15 MTARC2 MTCH2 MYLK NABP1 NDUFA5 NDUFAB1 NDUFB7 NDUFS3 NKIRAS1 NMT1 OMD ORM1 PDCD4 PEMT PEX14 PFKFB3 PFKL PGM1 PHLDB1 PHYH PIM3 PLIN2 POR PPARG PPM1B PPP1R15B PRDX3 PREB PTCD3 PTGER3 QDPR RAB34 REEP5 REEP6 RETN RETSAT RIOK3 RMDN3 RNF11 RREB1 RTN3 SAMM50 SCARB1 SCP2 SDHB SDHC SLC19A1 SLC1A5 SLC25A1 SLC25A10 SLC27A1 SLC5A6 SLC66A3 SNCG SOD1 SORBS1 SOWAHC SPARCL1 SQOR SSPN STAT5A STOM SUCLG1 SULT1A1 TALDO1 TANK TKT TOB1 TST UBC UBQLN1 UCK1 UCP2 UQCR10 UQCR11 UQCRC1 UQCRQ VEGFB YWHAG	200	7.643856189774724	Cellular Respiration 	GO:0045333	COX8A;COX7B;NDUFB7;NDUFA5;MDH2;SDHC;UQCR11;ETFB;UQCR10;COX6A1;SDHB;UQCRQ;NDUFAB1;NDUFS3;UQCRC1;CYC1	16	8	2.342467314196513e-16	3.2208925570202053e-13	Fatty Acid Metabolism and Oxidative Phosphorylation	"The most prominent biological process performed by this system of interacting proteins is fatty acid metabolism and oxidative phosphorylation. The proteins involved in these processes are essential for energy production and storage in cells.

Reasoning and Supporting Information:

1. Fatty Acid Metabolism: Several proteins in the list are involved in fatty acid metabolism, including ACAA2, ACADL, ACADM, ACADS, ACOX1, CPT2, ELOVL6, FABP4, and LPL. These proteins play crucial roles in the breakdown, synthesis, and transport of fatty acids, which are essential for energy production and storage in cells.

2. Oxidative Phosphorylation: Many proteins in the list are involved in oxidative phosphorylation, a process that generates ATP, the primary energy currency of cells. Key proteins include ATP5PO, COX6A1, COX7B, COX8A, CYC1, NDUFA5, NDUFAB1, NDUFB7, NDUFS3, SDHB, SDHC, UQCR10, UQCR11, UQCRC1, and UQCRQ. These proteins are components of the electron transport chain, which is responsible for the transfer of electrons and the generation of ATP.

3. Lipid Metabolism and Transport: Proteins such as ABCA1, CD36, and SCARB1 are involved in lipid metabolism and transport. These proteins play essential roles in the uptake, transport, and efflux of lipids, which are crucial for maintaining cellular lipid homeostasis.

4. Regulation of Metabolic Processes: Several proteins, such as PPARG, SREBF1, and STAT5A, are transcription factors that regulate the expression of genes involved in lipid and glucose metabolism. These proteins modulate cellular responses to changes in nutrient availability and energy demands.

5. Antioxidant Defense: Proteins such as CAT, GPX3, GPX4, PRDX3, and SOD1 are involved in antioxidant defense mechanisms. These proteins protect cells from oxidative stress by neutralizing reactive oxygen species, which can damage cellular components and impair cellular functions.

In conclusion, the most prominent biological process performed by this system of interacting proteins is fatty acid metabolism and oxidative phosphorylation. These processes are essential for energy production and storage in cells and are regulated by various proteins involved in lipid metabolism, transport, and antioxidant defense."	34	17	"The most prominent biological process performed by this system of interacting proteins is fatty acid metabolism and oxidative phosphorylation. The proteins involved in these processes are essential for energy production and storage in cells.

1. Fatty Acid Metabolism: Several proteins in the list are involved in fatty acid metabolism, including ACAA2, ACADL, ACADM, ACADS, ACOX1, CPT2, ELOVL6, FABP4, and LPL. These proteins play crucial roles in the breakdown, synthesis, and transport of fatty acids, which are essential for energy production and storage in cells.[1][2][3]

2. Oxidative Phosphorylation: Many proteins in the list are involved in oxidative phosphorylation, a process that generates ATP, the primary energy currency of cells. Key proteins include ATP5PO, COX6A1, COX7B, COX8A, CYC1, NDUFA5, NDUFAB1, NDUFB7, NDUFS3, SDHB, SDHC, UQCR10, UQCR11, UQCRC1, and UQCRQ. These proteins are components of the electron transport chain, which is responsible for the transfer of electrons and the generation of ATP.[4][5][6]

3. Lipid Metabolism and Transport: Proteins such as ABCA1, CD36, and SCARB1 are involved in lipid metabolism and transport. These proteins play essential roles in the uptake, transport, and efflux of lipids, which are crucial for maintaining cellular lipid homeostasis.[7][8][9]

4. Regulation of Metabolic Processes: Several proteins, such as PPARG, SREBF1, and STAT5A, are transcription factors that regulate the expression of genes involved in lipid and glucose metabolism. These proteins modulate cellular responses to changes in nutrient availability and energy demands.[10][11][12]

5. Antioxidant Defense: Proteins such as CAT, GPX3, GPX4, PRDX3, and SOD1 are involved in antioxidant defense mechanisms. These proteins protect cells from oxidative stress by neutralizing reactive oxygen species, which can damage cellular components and impair cellular functions.[13][14][15]

In conclusion, the most prominent biological process performed by this system of interacting proteins is fatty acid metabolism and oxidative phosphorylation. These processes are essential for energy production and storage in cells and are regulated by various proteins involved in lipid metabolism, transport, and antioxidant defense.

========================================================================================================================================================================================================
[1] Matsuzaka, Takashi, Shimano, Hitoshi. ""Elovl6: a new player in fatty acid metabolism and insulin sensitivity."" Journal of molecular medicine (Berlin, Germany), 2009, pp. 379-84.
[2] Rozovski, Uri, Grgurevic, Srdana, Bueso-Ramos, Carlos, Harris, David M, Li, Ping, Liu, Zhiming, Wu, Ji Yuan, Jain, Preetesh, Wierda, William, Burger, Jan, O'Brien, Susan, Jain, Nitin, Ferrajoli, Alessandra, Keating, Michael J, Estrov, Zeev. ""Aberrant LPL Expression, Driven by STAT3, Mediates Free Fatty Acid Metabolism in CLL Cells."" Molecular cancer research : MCR, 2015, pp. 944-53.
[3] Ma, Angel P Y, Yeung, Cherlie L S, Tey, Sze Keong, Mao, Xiaowen, Wong, Samuel W K, Ng, Tung Him, Ko, Frankie C F, Kwong, Ernest M L, Tang, Alexander H N, Ng, Irene Oi-Lin, Cai, Shao Hang, Yun, Jing Ping, Yam, Judy W P. ""Suppression of ACADM-Mediated Fatty Acid Oxidation Promotes Hepatocellular Carcinoma via Aberrant CAV1/SREBP1 Signaling."" Cancer research, 2021, pp. 3679-3692.
[4] Wang, HaiXia, Luo, JunTao, Tian, WenXia, Yan, WenQing, Ge, Sheng, Zhang, YaHui, Sun, WenGuang. ""γ-Tocotrienol inhibits oxidative phosphorylation and triggers apoptosis by inhibiting mitochondrial complex I subunit NDUFB8 and complex II subunit SDHB."" Toxicology, 2019, pp. 42-53.
[5] Cong, Hui, Gao, Jian, Wang, Qing, Du, Min, Li, Huimin, Li, Qian, Li, Jin, Liang, Yiyi, Zhao, Dan, Yang, Hancao, Gan, Yu, Tu, Hong. ""Increased Expression of Mitochondrial UQCRC1 in Pancreatic Cancer Impairs Antitumor Immunity of Natural Killer Cells <i>via</i> Elevating Extracellular ATP."" Frontiers in oncology, 2022, pp. 872017.
[6] Kim, Sup, Lee, June-Young, Shin, Seul Gi, Kim, Jin Kyung, Silwal, Prashanta, Kim, Young Jae, Shin, Na-Ri, Kim, Pil Soo, Won, Minho, Lee, Sang-Hee, Kim, Soo Yeon, Sasai, Miwa, Yamamoto, Masahiro, Kim, Jin-Man, Bae, Jin-Woo, Jo, Eun-Kyeong. ""ESRRA (estrogen related receptor alpha) is a critical regulator of intestinal homeostasis through activation of autophagic flux via gut microbiota."" Autophagy, 2021, pp. 2856-2875.
[7] Li, Yunxia, Huang, Xingguo, Yang, Guan, Xu, Kang, Yin, Yulong, Brecchia, Gabriele, Yin, Jie. ""CD36 favours fat sensing and transport to govern lipid metabolism."" Progress in lipid research, 2022, pp. 101193.
[8] Wu, Ya-Ru, Shi, Xiao-Yun, Ma, Chun-Yan, Zhang, Yue, Xu, Rui-Xia, Li, Jian-Jun. ""Liraglutide improves lipid metabolism by enhancing cholesterol efflux associated with ABCA1 and ERK1/2 pathway."" Cardiovascular diabetology, 2019, pp. 146.
[9] Zhao, Lei, Varghese, Z, Moorhead, J F, Chen, Yaxi, Ruan, Xiong Z. ""CD36 and lipid metabolism in the evolution of atherosclerosis."" British medical bulletin, 2018, pp. 101-112.
[10] Li, Li-Yan, Yang, Qian, Jiang, Yan-Yi, Yang, Wei, Jiang, Yuan, Li, Xiang, Hazawa, Masaharu, Zhou, Bo, Huang, Guo-Wei, Xu, Xiu-E, Gery, Sigal, Zhang, Ying, Ding, Ling-Wen, Ho, Allen S, Zumsteg, Zachary S, Wang, Ming-Rong, Fullwood, Melissa J, Freedland, Stephen J, Meltzer, Stephen J, Xu, Li-Yan, Li, En-Min, Koeffler, H Phillip, Lin, De-Chen. ""Interplay and cooperation between SREBF1 and master transcription factors regulate lipid metabolism and tumor-promoting pathways in squamous cancer."" Nature communications, 2021, pp. 4362.
[11] Ma, Sai, Zhou, Bo, Yang, Qian, Pan, Yunzhi, Yang, Wei, Freedland, Stephen J, Ding, Ling-Wen, Freeman, Michael R, Breunig, Joshua J, Bhowmick, Neil A, Pan, Jian, Koeffler, H Phillip, Lin, De-Chen. ""A Transcriptional Regulatory Loop of Master Regulator Transcription Factors, PPARG, and Fatty Acid Synthesis Promotes Esophageal Adenocarcinoma."" Cancer research, 2021, pp. 1216-1229.
[12] Hennighausen, Lothar, Robinson, Gertraud W. ""Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B."" Genes & development, 2008, pp. 711-21.
[13] Chen, Jing, Ou, Zhijie, Gao, Tiantian, Yang, Yuwei, Shu, Anmei, Xu, Huiqin, Chen, Yuping, Lv, Zhiyang. ""Ginkgolide B alleviates oxidative stress and ferroptosis by inhibiting GPX4 ubiquitination to improve diabetic nephropathy."" Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, pp. 113953.
[14] Zhang, Xuyang, Huang, Zhaobo, Xie, Ziang, Chen, Yilei, Zheng, Zeyu, Wei, Xiao'an, Huang, Bao, Shan, Zhi, Liu, Junhui, Fan, Shunwu, Chen, Jian, Zhao, Fengdong. ""Homocysteine induces oxidative stress and ferroptosis of nucleus pulposus via enhancing methylation of GPX4."" Free radical biology & medicine, 2020, pp. 552-565.
[15] Cui, Jiawen, Zhou, Qin, Yu, Meijin, Liu, Yuhao, Teng, Xiaohua, Gu, Xianhong. ""4-tert-butylphenol triggers common carp hepatocytes ferroptosis via oxidative stress, iron overload, SLC7A11/GSH/GPX4 axis, and ATF4/HSPA5/GPX4 axis."" Ecotoxicology and environmental safety, 2022, pp. 113944.
"	0.43707296	0.4533456	Tied	LLM	NA
MSigDB	ALLOGRAFT REJECTION	NA	AARS1 ABCE1 ABI1 ACHE ACVR2A AKT1 APBB1 B2M BCAT1 BCL10 BCL3 BRCA1 C2 CAPG CARTPT CCL11 CCL13 CCL19 CCL2 CCL22 CCL4 CCL5 CCL7 CCND2 CCND3 CCR1 CCR2 CCR5 CD1D CD2 CD247 CD28 CD3D CD3E CD3G CD4 CD40 CD40LG CD47 CD7 CD74 CD79A CD80 CD86 CD8A CD8B CD96 CDKN2A CFP CRTAM CSF1 CSK CTSS CXCL13 CXCL9 CXCR3 DARS1 DEGS1 DYRK3 EGFR EIF3A EIF3D EIF3J EIF4G3 EIF5A ELANE ELF4 EREG ETS1 F2 F2R FAS FASLG FCGR2B FGR FLNA FYB1 GALNT1 GBP2 GCNT1 GLMN GPR65 GZMA GZMB HCLS1 HDAC9 HIF1A HLA-A HLA-DMA HLA-DMB HLA-DOA HLA-DOB HLA-DQA1 HLA-DRA HLA-E HLA-G ICAM1 ICOSLG IFNAR2 IFNG IFNGR1 IFNGR2 IGSF6 IKBKB IL10 IL11 IL12A IL12B IL12RB1 IL13 IL15 IL16 IL18 IL18RAP IL1B IL2 IL27RA IL2RA IL2RB IL2RG IL4 IL4R IL6 IL7 IL9 INHBA INHBB IRF4 IRF7 IRF8 ITGAL ITGB2 ITK JAK2 KLRD1 KRT1 LCK LCP2 LIF LTB LY75 LY86 LYN MAP3K7 MAP4K1 MBL2 MMP9 MRPL3 MTIF2 NCF4 NCK1 NCR1 NLRP3 NME1 NOS2 NPM1 PF4 PRF1 PRKCB PRKCG PSMB10 PTPN6 PTPRC RARS1 RIPK2 RPL39 RPL3L RPL9 RPS19 RPS3A RPS9 SIT1 SOCS1 SOCS5 SPI1 SRGN ST8SIA4 STAB1 STAT1 STAT4 TAP1 TAP2 TAPBP TGFB1 TGFB2 THY1 TIMP1 TLR1 TLR2 TLR3 TLR6 TNF TPD52 TRAF2 TRAT1 UBE2D1 UBE2N WARS1 WAS ZAP70	200	7.643856189774724	Positive Regulation Of Cytokine Production 	GO:0001819	CD86;ITK;CD40;CD80;BRCA1;TNF;IL12B;IL12A;JAK2;MAP3K7;CCR2;MBL2;IL10;IL15;RIPK2;IL13;F2R;IL18;IL16;TRAF2;HLA-A;HLA-G;EREG;HLA-E;TLR1;FGR;IFNG;IRF4;IL1B;IRF7;TLR6;LTB;TLR3;TLR2;BCL10;HIF1A;NLRP3;CCL19;IL12RB1;ELANE;CD74;TGFB1;NOS2;CRTAM;GLMN;IL2;CD2;IL4;CD4;IL6;PTPRC;CD40LG;IL7;IL9;CD28	55	27.500000000000004	1.489018642538626e-52	3.091202701910188e-49	Immune Response Regulation	"The system of interacting proteins primarily performs the regulation of immune response. The proteins involved in this system can be categorized into several groups based on their functions:

1. Cytokines and their receptors: IL10, IL11, IL12A, IL12B, IL12RB1, IL13, IL15, IL16, IL18, IL18RAP, IL1B, IL2, IL27RA, IL2RA, IL2RB, IL2RG, IL4, IL4R, IL6, IL7, IL9, IFNAR2, IFNG, IFNGR1, IFNGR2, LIF, LTB, and TNF. These proteins are involved in the regulation of immune cell proliferation, differentiation, and activation.

2. Chemokines and their receptors: CCL11, CCL13, CCL19, CCL2, CCL22, CCL4, CCL5, CCL7, CCND2, CCND3, CCR1, CCR2, CCR5, CXCL13, CXCL9, and CXCR3. These proteins are responsible for the recruitment and migration of immune cells to the site of infection or inflammation.

3. T cell activation and signaling: CD1D, CD2, CD247, CD28, CD3D, CD3E, CD3G, CD4, CD40, CD40LG, CD7, CD74, CD79A, CD80, CD86, CD8A, CD8B, CD96, CRTAM, CSK, ELF4, ETS1, FAS, FASLG, FCGR2B, FGR, FLNA, FYB1, HCLS1, ICAM1, ICOSLG, ITGAL, ITGB2, ITK, JAK2, LCK, LCP2, LY75, LY86, LYN, MAP3K7, MAP4K1, NCK1, NCR1, PTPN6, PTPRC, SIT1, SOCS1, SOCS5, SPI1, STAT1, STAT4, TRAF2, TRAT1, UBE2D1, UBE2N, WAS, and ZAP70. These proteins are involved in the activation, differentiation, and function of T cells, which play a crucial role in adaptive immunity.

4. Antigen processing and presentation: B2M, HLA-A, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DQA1, HLA-DRA, HLA-E, HLA-G, TAP1, TAP2, and TAPBP. These proteins are responsible for the processing and presentation of antigens to T cells, initiating the adaptive immune response.

5. Innate immune response: C2, CAPG, CARTPT, CD47, CTSS, DEGS1, DYRK3, EGFR, EIF3A, EIF3D, EIF3J, EIF4G3, EIF5A, ELANE, F2, F2R, GBP2, GCNT1, GLMN, GPR65, GZMA, GZMB, HDAC9, HIF1A, IKBKB, IL1B, INHBA, INHBB, IRF4, IRF7, IRF8, KLRD1, KRT1, MBL2, MMP9, MRPL3, MTIF2, NCF4, NLRP3, NME1, NOS2, NPM1, PF4, PRF1, PRKCB, PRKCG, PSMB10, RARS1, RIPK2, RPL39, RPL3L, RPL9, RPS19, RPS3A, RPS9, SRGN, ST8SIA4, STAB1, TLR1, TLR2, TLR3, TLR6, TPD52, and UBE2D1. These proteins are involved in the recognition, phagocytosis, and destruction of pathogens, as well as the activation of the adaptive immune response.

In conclusion, the most prominent biological process performed by this system of interacting proteins is the regulation of immune response, which includes the activation and function of both innate and adaptive immunity. The proteins involved in this system work together to recognize, respond to, and eliminate pathogens, as well as to maintain immune homeostasis."	177	88.5	"The system of interacting proteins primarily performs the regulation of immune response. The proteins involved in this system can be categorized into several groups based on their functions:

1. Cytokines and their receptors: IL10, IL11, IL12A, IL12B, IL12RB1, IL13, IL15, IL16, IL18, IL18RAP, IL1B, IL2, IL27RA, IL2RA, IL2RB, IL2RG, IL4, IL4R, IL6, IL7, IL9, IFNAR2, IFNG, IFNGR1, IFNGR2, LIF, LTB, and TNF. These proteins are involved in the regulation of immune cell proliferation, differentiation, and activation.[1][2][3]

2. Chemokines and their receptors: CCL11, CCL13, CCL19, CCL2, CCL22, CCL4, CCL5, CCL7, CCND2, CCND3, CCR1, CCR2, CCR5, CXCL13, CXCL9, and CXCR3. These proteins are responsible for the recruitment and migration of immune cells to the site of infection or inflammation.[4][5][6]

3. T cell activation and signaling: CD1D, CD2, CD247, CD28, CD3D, CD3E, CD3G, CD4, CD40, CD40LG, CD7, CD74, CD79A, CD80, CD86, CD8A, CD8B, CD96, CRTAM, CSK, ELF4, ETS1, FAS, FASLG, FCGR2B, FGR, FLNA, FYB1, HCLS1, ICAM1, ICOSLG, ITGAL, ITGB2, ITK, JAK2, LCK, LCP2, LY75, LY86, LYN, MAP3K7, MAP4K1, NCK1, NCR1, PTPN6, PTPRC, SIT1, SOCS1, SOCS5, SPI1, STAT1, STAT4, TRAF2, TRAT1, UBE2D1, UBE2N, WAS, and ZAP70. These proteins are involved in the activation, differentiation, and function of T cells, which play a crucial role in adaptive immunity.[7][8][9]

4. Antigen processing and presentation: B2M, HLA-A, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DQA1, HLA-DRA, HLA-E, HLA-G, TAP1, TAP2, and TAPBP. These proteins are responsible for the processing and presentation of antigens to T cells, initiating the adaptive immune response.[10][11][12]

5. Innate immune response: C2, CAPG, CARTPT, CD47, CTSS, DEGS1, DYRK3, EGFR, EIF3A, EIF3D, EIF3J, EIF4G3, EIF5A, ELANE, F2, F2R, GBP2, GCNT1, GLMN, GPR65, GZMA, GZMB, HDAC9, HIF1A, IKBKB, IL1B, INHBA, INHBB, IRF4, IRF7, IRF8, KLRD1, KRT1, MBL2, MMP9, MRPL3, MTIF2, NCF4, NLRP3, NME1, NOS2, NPM1, PF4, PRF1, PRKCB, PRKCG, PSMB10, RARS1, RIPK2, RPL39, RPL3L, RPL9, RPS19, RPS3A, RPS9, SRGN, ST8SIA4, STAB1, TLR1, TLR2, TLR3, TLR6, TPD52, and UBE2D1. These proteins are involved in the recognition, phagocytosis, and destruction of pathogens, as well as the activation of the adaptive immune response.[13][14][15]

In conclusion, the most prominent biological process performed by this system of interacting proteins is the regulation of immune response, which includes the activation and function of both innate and adaptive immunity. The proteins involved in this system work together to recognize, respond to, and eliminate pathogens, as well as to maintain immune homeostasis.

========================================================================================================================================================================================================
[1] Ouyang, Wenjun, Rutz, Sascha, Crellin, Natasha K, Valdez, Patricia A, Hymowitz, Sarah G. ""Regulation and functions of the IL-10 family of cytokines in inflammation and disease."" Annual review of immunology, 2011, pp. 71-109.
[2] Ouyang, Wenjun, O'Garra, Anne. ""IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation."" Immunity, 2019, pp. 871-891.
[3] De Simone, V, Franzè, E, Ronchetti, G, Colantoni, A, Fantini, M C, Di Fusco, D, Sica, G S, Sileri, P, MacDonald, T T, Pallone, F, Monteleone, G, Stolfi, C. ""Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth."" Oncogene, 2015, pp. 3493-503.
[4] Valdés, Natalia, Cortés, Marcos, Barraza, Felipe, Reyes-López, Felipe E, Imarai, Mónica. ""CXCL9-11 chemokines and CXCR3 receptor in teleost fish species."" Fish and shellfish immunology reports, 2022, pp. 100068.
[5] Knipping, Friederike, Newby, Gregory A, Eide, Cindy R, McElroy, Amber N, Nielsen, Sarah C, Smith, Kyle, Fang, Yongxing, Cornu, Tatjana I, Costa, Caroline, Gutierrez-Guerrero, Alejandra, Bingea, Samuel P, Feser, Colby J, Steinbeck, Benjamin, Hippen, Keli L, Blazar, Bruce R, McCaffrey, Anton, Mussolino, Claudio, Verhoeyen, Els, Tolar, Jakub, Liu, David R, Osborn, Mark J. ""Disruption of HIV-1 co-receptors CCR5 and CXCR4 in primary human T cells and hematopoietic stem and progenitor cells using base editing."" Molecular therapy : the journal of the American Society of Gene Therapy, 2022, pp. 130-144.
[6] Fuhro, Maria Isabel, Andrade, Francini P, Dorneles, Gilson P, Lira, Fabio S, Romão, Pedro Rt, Peres, Alessandra, Monteiro, Mariane. ""The impact of intradialytic exercise on immune cells expressing CCR5+ in patients with chronic kidney disease: A cross-over trial."" The International journal of artificial organs, 2022, pp. 221-226.
[7] Zhou, Yunfeng, Zhang, Haibo, Yao, Yao, Zhang, Xiaoyan, Guan, Youfei, Zheng, Feng. ""CD4<sup>+</sup> T cell activation and inflammation in NASH-related fibrosis."" Frontiers in immunology, 2022, pp. 967410.
[8] Wu, Jun, Li, Gen, Li, Le, Li, Dan, Dong, Zhongjun, Jiang, Peng. ""Asparagine enhances LCK signalling to potentiate CD8<sup>+</sup> T-cell activation and anti-tumour responses."" Nature cell biology, 2021, pp. 75-86.
[9] Sugiura, Daisuke, Okazaki, Il-Mi, Maeda, Takeo K, Maruhashi, Takumi, Shimizu, Kenji, Arakaki, Rieko, Takemoto, Tatsuya, Ishimaru, Naozumi, Okazaki, Taku. ""PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity."" Nature immunology, 2022, pp. 399-410.
[10] Wu, Z, Biro, P A, Mirakian, R, Hammond, L, Curcio, F, Ambesi-Impiombato, F S, Bottazzo, G F. ""HLA-DMB expression by thyrocytes: indication of the antigen-processing and possible presenting capability of thyroid cells."" Clinical and experimental immunology, 1999, pp. 62-9.
[11] Tabassum, Anika, Samdani, Md Nazmus, Dhali, Tarak Chandra, Alam, Rahat, Ahammad, Foysal, Samad, Abdus, Karpiński, Tomasz M. ""Transporter associated with antigen processing 1 (TAP1) expression and prognostic analysis in breast, lung, liver, and ovarian cancer."" Journal of molecular medicine (Berlin, Germany), 2021, pp. 1293-1309.
[12] Foley, P J, Lympany, P A, Puscinska, E, Zielinski, J, Welsh, K I, du Bois, R M. ""Analysis of MHC encoded antigen-processing genes TAP1 and TAP2 polymorphisms in sarcoidosis."" American journal of respiratory and critical care medicine, 1999, pp. 1009-14.
[13] Koumangoye, Rainelli. ""The role of Cl<sup>-</sup> and K<sup>+</sup> efflux in NLRP3 inflammasome and innate immune response activation."" American journal of physiology. Cell physiology, 2022, pp. C645-C652.
[14] Yu, Ningli, Xu, Xiaowen, Qi, Guoqin, Liu, Dan, Chen, Xin, Ran, Xiaoqin, Jiang, Zeyin, Li, Yinping, Mao, Huiling, Hu, Chengyu. ""Ctenopharyngodon idella TBK1 activates innate immune response via IRF7."" Fish & shellfish immunology, 2018, pp. 521-527.
[15] Kojima, Yoko, Volkmer, Jens-Peter, McKenna, Kelly, Civelek, Mete, Lusis, Aldons Jake, Miller, Clint L, Direnzo, Daniel, Nanda, Vivek, Ye, Jianqin, Connolly, Andrew J, Schadt, Eric E, Quertermous, Thomas, Betancur, Paola, Maegdefessel, Lars, Matic, Ljubica Perisic, Hedin, Ulf, Weissman, Irving L, Leeper, Nicholas J. ""CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis."" Nature, 2016, pp. 86-90.
"	0.43272007	0.18633658	LLM	LLM	NA
MSigDB	ANDROGEN RESPONSE	NA	ABCC4 ABHD2 ACSL3 ACTN1 ADAMTS1 ADRM1 AKAP12 AKT1 ALDH1A3 ANKH APPBP2 ARID5B AZGP1 B2M B4GALT1 BMPR1B CAMKK2 CCND1 CCND3 CDC14B CDK6 CENPN DBI DHCR24 DNAJB9 ELK4 ELL2 ELOVL5 FADS1 FKBP5 GNAI3 GPD1L GSR GUCY1A1 H1-0 HERC3 HMGCR HMGCS1 HOMER2 HPGD HSD17B14 IDI1 INPP4B INSIG1 IQGAP2 ITGAV KLK2 KLK3 KRT19 KRT8 LIFR LMAN1 MAF MAK MAP7 MERTK MYL12A NCOA4 NDRG1 NGLY1 NKX3-1 PA2G4 PDLIM5 PGM3 PIAS1 PLPP1 PMEPA1 PTK2B PTPN21 RAB4A RPS6KA3 RRP12 SAT1 SCD SEC24D SELENOP SGK1 SLC26A2 SLC38A2 SMS SORD SPCS3 SPDEF SRF SRP19 STEAP4 STK39 TARP TMEM50A TMPRSS2 TNFAIP8 TPD52 TSC22D1 UAP1 UBE2I UBE2J1 VAPA XRCC5 XRCC6 ZBTB10 ZMIZ1	101	6.658211482751795	Androgen Receptor Signaling Pathway 	GO:0030521	ZMIZ1;PMEPA1;PLPP1;NKX3-1	4	3.9603960396039604	1.3861013554149986e-6	8.23331325743e-4	Cholesterol Biosynthesis and Regulation	"The most prominent biological process performed by this system of interacting proteins is cholesterol biosynthesis and regulation. This conclusion is based on the presence of several key proteins involved in this process, including HMGCR, HMGCS1, DHCR24, IDI1, INSIG1, and SREBF1.

1. HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase) is the rate-limiting enzyme in cholesterol biosynthesis, catalyzing the conversion of HMG-CoA to mevalonate. Its activity is regulated by feedback inhibition from cholesterol and its derivatives, as well as by phosphorylation by AMP-activated protein kinase (AMPK).

2. HMGCS1 (3-hydroxy-3-methylglutaryl-CoA synthase 1) is another key enzyme in cholesterol biosynthesis, catalyzing the condensation of acetyl-CoA and acetoacetyl-CoA to form HMG-CoA.

3. DHCR24 (24-dehydrocholesterol reductase) catalyzes the final step in cholesterol biosynthesis, converting desmosterol to cholesterol.

4. IDI1 (isopentenyl-diphosphate delta isomerase 1) is involved in the isoprenoid biosynthesis pathway, which is essential for the production of cholesterol and other isoprenoids.

5. INSIG1 (insulin-induced gene 1) is a key regulator of cholesterol homeostasis, binding to HMGCR and SREBF1 (sterol regulatory element-binding transcription factor 1) to inhibit cholesterol synthesis and uptake when cellular cholesterol levels are high.

6. SREBF1 is a transcription factor that regulates the expression of genes involved in cholesterol and fatty acid biosynthesis, including HMGCR and HMGCS1. Its activity is regulated by proteolytic cleavage in response to cellular cholesterol levels.

In addition to cholesterol biosynthesis and regulation, this system of interacting proteins is also involved in other important cellular processes, such as protein folding and degradation (DNAJB9, UBE2I, UBE2J1), cell cycle regulation (CCND1, CCND3, CDK6, CDC14B), and signal transduction (AKT1, CAMKK2, GNAI3, GUCY1A1, PTK2B, RPS6KA3, SGK1). However, the prominence of key proteins in cholesterol biosynthesis and regulation suggests that this is the most significant process performed by this system."	19	18.81188118811881	"The most prominent biological process performed by this system of interacting proteins is cholesterol biosynthesis and regulation. This conclusion is based on the presence of several key proteins involved in this process, including HMGCR, HMGCS1, DHCR24, IDI1, INSIG1, and SREBF1.[1][2][3]

1. HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase) is the rate-limiting enzyme in cholesterol biosynthesis, catalyzing the conversion of HMG-CoA to mevalonate. Its activity is regulated by feedback inhibition from cholesterol and its derivatives, as well as by phosphorylation by AMP-activated protein kinase (AMPK).[4][5][6]

2. HMGCS1 (3-hydroxy-3-methylglutaryl-CoA synthase 1) is another key enzyme in cholesterol biosynthesis, catalyzing the condensation of acetyl-CoA and acetoacetyl-CoA to form HMG-CoA.[7][8][9]

3. DHCR24 (24-dehydrocholesterol reductase) catalyzes the final step in cholesterol biosynthesis, converting desmosterol to cholesterol.[10][11][12]

4. IDI1 (isopentenyl-diphosphate delta isomerase 1) is involved in the isoprenoid biosynthesis pathway, which is essential for the production of cholesterol and other isoprenoids.[13][14][15]

5. INSIG1 (insulin-induced gene 1) is a key regulator of cholesterol homeostasis, binding to HMGCR and SREBF1 (sterol regulatory element-binding transcription factor 1) to inhibit cholesterol synthesis and uptake when cellular cholesterol levels are high.[16][17][18]

6. SREBF1 is a transcription factor that regulates the expression of genes involved in cholesterol and fatty acid biosynthesis, including HMGCR and HMGCS1. Its activity is regulated by proteolytic cleavage in response to cellular cholesterol levels.[19][20][21]

In addition to cholesterol biosynthesis and regulation, this system of interacting proteins is also involved in other important cellular processes, such as protein folding and degradation (DNAJB9, UBE2I, UBE2J1), cell cycle regulation (CCND1, CCND3, CDK6, CDC14B), and signal transduction (AKT1, CAMKK2, GNAI3, GUCY1A1, PTK2B, RPS6KA3, SGK1). However, the prominence of key proteins in cholesterol biosynthesis and regulation suggests that this is the most significant process performed by this system.[22][23][24]

========================================================================================================================================================================================================
[1] Lu, Xiao-Yi, Shi, Xiong-Jie, Hu, Ao, Wang, Ju-Qiong, Ding, Yi, Jiang, Wei, Sun, Ming, Zhao, Xiaolu, Luo, Jie, Qi, Wei, Song, Bao-Liang. ""Feeding induces cholesterol biosynthesis via the mTORC1-USP20-HMGCR axis."" Nature, 2020, pp. 479-484.
[2] Shen, Yajie, Zhou, Jingqi, Nie, Kui, Cheng, Shuhua, Chen, Zhengming, Wang, Wenhan, Wei, Weiqing, Jiang, Daiji, Peng, Zijing, Ren, Yizhuo, Zhang, Yirong, Fan, Qiuju, Richards, Kristy L, Qi, Yitao, Cheng, Jinke, Tam, Wayne, Ma, Jiao. ""Oncogenic role of the SOX9-DHCR24-cholesterol biosynthesis axis in IGH-BCL2+ diffuse large B-cell lymphomas."" Blood, 2022, pp. 73-86.
[3] Frutos, Mario Fernández-de, Pardo-Marqués, Virginia, Torrecilla-Parra, Marta, Rada, Patricia, Pérez-García, Ana, Martín-Martín, Yolanda, de la Peña, Gema, Gómez, Ana, Toledano-Zaragoza, Ana, Gómez-Coronado, Diego, Casarejos, María José, Solís, José M, Rotllan, Noemí, Pastor, Óscar, Ledesma, María Dolores, Valverde, Ángela M, Busto, Rebeca, Ramírez, Cristina M. """"MiR-7 controls cholesterol biosynthesis through posttranscriptional regulation of DHCR24 expression""."" Biochimica et biophysica acta. Gene regulatory mechanisms, 2023, pp. 194938.
[4] Lu, Xiao-Yi, Shi, Xiong-Jie, Hu, Ao, Wang, Ju-Qiong, Ding, Yi, Jiang, Wei, Sun, Ming, Zhao, Xiaolu, Luo, Jie, Qi, Wei, Song, Bao-Liang. ""Feeding induces cholesterol biosynthesis via the mTORC1-USP20-HMGCR axis."" Nature, 2020, pp. 479-484.
[5] Li, Qingrong, Zhang, Hongmin, Zou, Jun, Feng, Xiang, Feng, Dan. ""Bisphenol A induces cholesterol biosynthesis in HepG2 cells via SREBP-2/HMGCR signaling pathway."" The Journal of toxicological sciences, 2019, pp. 481-491.
[6] Loregger, Anke, Raaben, Matthijs, Tan, Josephine, Scheij, Saskia, Moeton, Martina, van den Berg, Marlene, Gelberg-Etel, Hila, Stickel, Elmer, Roitelman, Joseph, Brummelkamp, Thijn, Zelcer, Noam. ""Haploid Mammalian Genetic Screen Identifies UBXD8 as a Key Determinant of HMGCR Degradation and Cholesterol Biosynthesis."" Arteriosclerosis, thrombosis, and vascular biology, 2017, pp. 2064-2074.
[7] Ma, Xiaoyao, Bai, Yongping, Liu, Kaixin, Han, Yiman, Zhang, Jinling, Liu, Yuteng, Hou, Xiaotao, Hao, Erwei, Hou, Yuanyuan, Bai, Gang. ""Ursolic acid inhibits the cholesterol biosynthesis and alleviates high fat diet-induced hypercholesterolemia via irreversible inhibition of HMGCS1 in vivo."" Phytomedicine : international journal of phytotherapy and phytopharmacology, 2022, pp. 154233.
[8] Walsh, Claire A, Akrap, Nina, Garre, Elena, Magnusson, Ylva, Harrison, Hannah, Andersson, Daniel, Jonasson, Emma, Rafnsdottir, Svanheidur, Choudhry, Hani, Buffa, Francesca, Ragoussis, Jiannis, Ståhlberg, Anders, Harris, Adrian, Landberg, Göran. ""The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer."" PloS one, 2020, pp. e0236187.
[9] Chen, Yiyan, Li, Min, Yang, Yanying, Lu, Yan, Li, Xiaoying. ""Antidiabetic drug metformin suppresses tumorigenesis through inhibition of mevalonate pathway enzyme HMGCS1."" The Journal of biological chemistry, 2022, pp. 102678.
[10] Shen, Yajie, Zhou, Jingqi, Nie, Kui, Cheng, Shuhua, Chen, Zhengming, Wang, Wenhan, Wei, Weiqing, Jiang, Daiji, Peng, Zijing, Ren, Yizhuo, Zhang, Yirong, Fan, Qiuju, Richards, Kristy L, Qi, Yitao, Cheng, Jinke, Tam, Wayne, Ma, Jiao. ""Oncogenic role of the SOX9-DHCR24-cholesterol biosynthesis axis in IGH-BCL2+ diffuse large B-cell lymphomas."" Blood, 2022, pp. 73-86.
[11] Drzewińska, Joanna, Pułaski, Lukasz, Soszyński, Mirosław, Bartosz, Grzegorz. ""[Seladin-1/DHCR24: a key protein of cell homeostasis and cholesterol biosynthesis]."" Postepy higieny i medycyny doswiadczalnej (Online), 2009, pp. 318-30.
[12] Wu, Jie, Guo, Ling, Qiu, Xiaoran, Ren, Yong, Li, Feifei, Cui, Wei, Song, Shaojiang. ""Genkwadaphnin inhibits growth and invasion in hepatocellular carcinoma by blocking DHCR24-mediated cholesterol biosynthesis and lipid rafts formation."" British journal of cancer, 2020, pp. 1673-1685.
[13] Pankratov, Ilya, McQuinn, Ryan, Schwartz, Jochanan, Bar, Einat, Fei, Zhangjun, Lewinsohn, Efraim, Zamir, Dani, Giovannoni, James J, Hirschberg, Joseph. ""Fruit carotenoid-deficient mutants in tomato reveal a function of the plastidial isopentenyl diphosphate isomerase (IDI1) in carotenoid biosynthesis."" The Plant journal : for cell and molecular biology, 2016, pp. 82-94.
[14] Phillips, Michael A, D'Auria, John C, Gershenzon, Jonathan, Pichersky, Eran. ""The Arabidopsis thaliana type I Isopentenyl Diphosphate Isomerases are targeted to multiple subcellular compartments and have overlapping functions in isoprenoid biosynthesis."" The Plant cell, 2008, pp. 677-96.
[15] Breitling, Rainer, Laubner, Daniela, Clizbe, Daun, Adamski, Jerzy, Krisans, Skaidrite K. ""Isopentenyl-diphosphate isomerases in human and mouse: evolutionary analysis of a mammalian gene duplication."" Journal of molecular evolution, 2003, pp. 282-91.
[16] Gong, Yi, Lee, Joon No, Brown, Michael S, Goldstein, Joseph L, Ye, Jin. ""Juxtamembranous aspartic acid in Insig-1 and Insig-2 is required for cholesterol homeostasis."" Proceedings of the National Academy of Sciences of the United States of America, 2006, pp. 6154-9.
[17] Yang, Tong, Espenshade, Peter J, Wright, Michael E, Yabe, Daisuke, Gong, Yi, Aebersold, Ruedi, Goldstein, Joseph L, Brown, Michael S. ""Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER."" Cell, 2002, pp. 489-500.
[18] Janowski, Bethany A. ""The hypocholesterolemic agent LY295427 up-regulates INSIG-1, identifying the INSIG-1 protein as a mediator of cholesterol homeostasis through SREBP."" Proceedings of the National Academy of Sciences of the United States of America, 2002, pp. 12675-80.
[19] Lu, Xiao-Yi, Shi, Xiong-Jie, Hu, Ao, Wang, Ju-Qiong, Ding, Yi, Jiang, Wei, Sun, Ming, Zhao, Xiaolu, Luo, Jie, Qi, Wei, Song, Bao-Liang. ""Feeding induces cholesterol biosynthesis via the mTORC1-USP20-HMGCR axis."" Nature, 2020, pp. 479-484.
[20] Ma, Xiaoyao, Bai, Yongping, Liu, Kaixin, Han, Yiman, Zhang, Jinling, Liu, Yuteng, Hou, Xiaotao, Hao, Erwei, Hou, Yuanyuan, Bai, Gang. ""Ursolic acid inhibits the cholesterol biosynthesis and alleviates high fat diet-induced hypercholesterolemia via irreversible inhibition of HMGCS1 in vivo."" Phytomedicine : international journal of phytotherapy and phytopharmacology, 2022, pp. 154233.
[21] Zheng, Zu-Guo, Zhu, Si-Tong, Cheng, Hui-Min, Zhang, Xin, Cheng, Gang, Thu, Pyone Myat, Wang, Supeng Perry, Li, Hui-Jun, Ding, Ming, Qiang, Lei, Chen, Xiao-Wei, Zhong, Qing, Li, Ping, Xu, Xiaojun. ""Discovery of a potent SCAP degrader that ameliorates HFD-induced obesity, hyperlipidemia and insulin resistance via an autophagy-independent lysosomal pathway."" Autophagy, 2021, pp. 1592-1613.
[22] Wang, Qiong, He, Guopei, Hou, Mengmeng, Chen, Liutao, Chen, Shangwu, Xu, Anlong, Fu, Yonggui. ""Cell Cycle Regulation by Alternative Polyadenylation of CCND1."" Scientific reports, 2018, pp. 6824.
[23] Rashkovan, Marissa, Albero, Robert, Gianni, Francesca, Perez-Duran, Pablo, Miller, Hannah I, Mackey, Adam L, Paietta, Elisabeth M, Tallman, Martin S, Rowe, Jacob M, Litzow, Mark R, Wiernik, Peter H, Luger, Selina, Sulis, Maria Luisa, Soni, Rajesh K, Ferrando, Adolfo A. ""Intracellular Cholesterol Pools Regulate Oncogenic Signaling and Epigenetic Circuitries in Early T-cell Precursor Acute Lymphoblastic Leukemia."" Cancer discovery, 2022, pp. 856-871.
[24] Liu, Jia, Cao, Lei, Qu, Jun-Ze, Chen, Ting-Ting, Su, Zi-Jie, Hu, Yun-Long, Wang, Ying, Yao, Ming-Dong, Xiao, Wen-Hai, Li, Chun, Li, Bo, Yuan, Ying-Jin. ""NVD-BM-mediated genetic biosensor triggers accumulation of 7-dehydrocholesterol and inhibits melanoma via Akt1/NF-ĸB signaling."" Aging, 2020, pp. 15021-15036.
"	0.47084036	0.6878784	GO	GO	NA
